1932

Abstract

The emergence of novel zoonotic pathogens is one of the greatest challenges to global health security. The advent of increasingly sophisticated diagnostics tools has revolutionized our capacity to detect and respond to these health threats more rapidly than ever before. Yet, no matter how sophisticated these tools become, the initial identification of emerging infectious diseases begins at the local community level. It is here that the initial human or animal case resides, and it is here that early pathogen detection would have maximum benefit. Unfortunately, many areas at highest risk of zoonotic disease emergence lack sufficient infrastructure capacity to support robust laboratory diagnostic systems. Multiple factors are essential for pathogen detection networks, including an understanding of the complex sociological and ecological factors influencing disease transmission risk, community engagement, surveillance along high-risk human-animal interfaces, and a skilled laboratory workforce. Here we discuss factors relevant to the emerging disease paradigm, recent technical advances in diagnostic methods, and strategies for comprehensive and sustainable approaches to rapid zoonotic disease detection.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-animal-030117-014628
2018-02-15
2024-06-23
Loading full text...

Full text loading...

/deliver/fulltext/animal/6/1/annurev-animal-030117-014628.html?itemId=/content/journals/10.1146/annurev-animal-030117-014628&mimeType=html&fmt=ahah

Literature Cited

  1. World Bank. 1.  2010. People, Pathogens, and Our Planet 1 Towards a One Health Approach for Controlling Zoonotic Diseases Washington, DC: World Bank [Google Scholar]
  2. Cleaveland S, Laurenson MK, Taylor LH. 2.  2001. Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:991–99 [Google Scholar]
  3. Daszak P, Cunningham AA, Hyatt AD. 3.  2000. Emerging infectious diseases of wildlife—threats to biodiversity and human health. Science 287:443–49 [Google Scholar]
  4. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D. 4.  et al. 2008. Global trends in emerging infectious diseases. Nature 451:990–93 [Google Scholar]
  5. Woolhouse MEJ, Gowtage-Sequeria S. 5.  2005. Host range and emerging and reemerging pathogens. Emerg. Infect. Dis. 11:1842–47 [Google Scholar]
  6. Woolhouse M, Gaunt E. 6.  2007. Ecological origins of novel human pathogens. Crit. Rev. Microbiol. 33:231–42 [Google Scholar]
  7. Taylor LH, Latham SM, Woolhouse ME. 7.  2001. Risk factors for human disease emergence. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:983–89 [Google Scholar]
  8. 8. Natl. Inst. Allergy Infect. Dis. 2016. NIAID Emerging Infectious Diseases/Pathogens Bethesda, MD: Natl. Inst. Allergy Infect. Dis https://www.niaid.nih.gov/research/emerging-infectious-diseases-pathogens [Google Scholar]
  9. Anthony SJ, Epstein JH, Murray KA, Navarrete-Macias I, Zambrana-Torrelio CM. 9.  et al. 2013. A strategy to estimate unknown viral diversity in mammals. mBio 4:e00598–13 [Google Scholar]
  10. Bebber DP, Marriott FH, Gaston KJ, Harris SA, Scotland RW. 10.  2007. Predicting unknown species numbers using discovery curves. Proc. Biol. Sci. 274:1651–58 [Google Scholar]
  11. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L. 11.  et al. 2014. Emergence of Zaire Ebola virus disease in Guinea. N. Engl. J. Med. 371:1418–25 [Google Scholar]
  12. Dixon MG, Schafer IJ. 12.  2014. Ebola viral disease outbreak—West Africa, 2014.. Morb. Mortal. Wkly. Rep. 63:548–51 [Google Scholar]
  13. Dudas G, Carvalho LM, Bedford T, Tatem AJ, Baele G. 13.  et al. 2017. Virus genomes reveal factors that spread and sustained the Ebola epidemic. Nature 544:309–15 [Google Scholar]
  14. 14. World Health Organ. 1978. Ebola haemorrhagic fever in Zaire, 1976.. Bull. World Health Organ. 56:271–93 [Google Scholar]
  15. 15. World Health Organ. 1978. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull. World Health Organ. 56:247–70 [Google Scholar]
  16. Johnson KM, Lange JV, Webb PA, Murphy FA. 16.  1977. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet 1:569–71 [Google Scholar]
  17. Coltart CE, Lindsey B, Ghinai I, Johnson AM, Heymann DL. 17.  2017. The Ebola outbreak, 2013–2016: old lessons for new epidemics. Philos. Trans. R. Soc. Lond. B Biol. Sci. 372:20160297 [Google Scholar]
  18. Bell BP, Damon IK, Jernigan DB, Kenyon TA, Nichol ST. 18.  et al. 2016. Overview, control strategies, and lessons learned in the CDC response to the 2014–2016 Ebola epidemic. Morb. Mortal. Wkly. Rep. 65:Suppl.4–11 [Google Scholar]
  19. Engering A, Hogerwerf L, Slingenbergh J. 19.  2013. Pathogen-host-environment interplay and disease emergence. Emerg Microbes Infect 2:e5 [Google Scholar]
  20. Lederberg JSR, Oaks SC. 20.  1992. Emerging Infections: Microbial Threats to Health in the United States Washington, DC: Natl. Acad. Press [Google Scholar]
  21. Woolhouse MEJ, Dye C. 21.  2001. Preface: population biology of emerging and re-emerging pathogens. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:981–82 [Google Scholar]
  22. Briese T, Paweska JT, McMullan LK, Hutchison SK, Street C. 22.  et al. 2009. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLOS Pathog 5:e1000455 [Google Scholar]
  23. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR. 23.  et al. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:1967–76 [Google Scholar]
  24. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T. 24.  et al. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:1953–66 [Google Scholar]
  25. McMullan LK, Folk SM, Kelly AJ, MacNeil A, Goldsmith CS. 25.  et al. 2012. A new phlebovirus associated with severe febrile illness in Missouri. N. Engl. J. Med. 367:834–41 [Google Scholar]
  26. Briese T, Jia XY, Huang C, Grady LJ, Lipkin WI. 26.  1999. Identification of a Kunjin/West Nile-like flavivirus in brains of patients with New York encephalitis. Lancet 354:1261–62 [Google Scholar]
  27. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M. 27.  et al. 1999. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286:2333–37 [Google Scholar]
  28. 28. Cent. Dis. Control Prev. 1997. Isolation of avian influenza A(H5N1) viruses from humans—Hong Kong, May-December 1997. Morb. Mortal. Wkly. Rep. 46:1204–7 [Google Scholar]
  29. 29. Cent. Dis. Control Prev. 1999. Update: outbreak of Nipah virus—Malaysia and Singapore, 1999. Morb. Mortal. Wkly. Rep. 48:335–37 [Google Scholar]
  30. Martines RB, Bhatnagar J, Keating MK, Silva-Flannery L, Muehlenbachs A. 30.  et al. 2016. Notes from the field: evidence of Zika virus infection in brain and placental tissues from two congenitally infected newborns and two fetal losses—Brazil, 2015.. Morb. Mortal. Wkly. Rep. 65:159–60 [Google Scholar]
  31. Ritter JM, Martines RB, Zaki SR. 31.  2017. Zika virus: pathology from the pandemic. Arch. Pathol. Lab. Med. 141:49–59 [Google Scholar]
  32. Hu Y, Gao GF, Zhu B. 32.  2017. The antibiotic resistome: gene flow in environments, animals and human beings. Front. Med. 11:161–68 [Google Scholar]
  33. Linthicum KJ, Anyamba A, Tucker CJ, Kelley PW, Myers MF, Peters CJ. 33.  1999. Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science 285:397–400 [Google Scholar]
  34. Diack AB, Head MW, McCutcheon S, Boyle A, Knight R. 34.  et al. 2014. Variant CJD. 18 years of research and surveillance. Prion 8:286–95 [Google Scholar]
  35. Wolfe ND, Dunavan CP, Diamond J. 35.  2007. Origins of major human infectious diseases. Nature 447:279–83 [Google Scholar]
  36. Lloyd-Smith JO, George D, Pepin KM, Pitzer VE, Pulliam JR. 36.  et al. 2009. Epidemic dynamics at the human-animal interface. Science 326:1362–67 [Google Scholar]
  37. Morse SS, Mazet JA, Woolhouse M, Parrish CR, Carroll D. 37.  et al. 2012. Prediction and prevention of the next pandemic zoonosis. Lancet 380:1956–65 [Google Scholar]
  38. Johnson CK, Hitchens PL, Evans TS, Goldstein T, Thomas K. 38.  et al. 2015. Spillover and pandemic properties of zoonotic viruses with high host plasticity. Sci. Rep. 5:14830 [Google Scholar]
  39. Harper KN, Armelagos GJ. 39.  2013. Genomics, the origins of agriculture, and our changing microbe-scape: time to revisit some old tales and tell some new ones. Am. J. Phys. Anthropol. 152:Suppl. 57135–52 [Google Scholar]
  40. Gottdenker NL, Streicker DG, Faust CL, Carroll CR. 40.  2014. Anthropogenic land use change and infectious diseases: a review of the evidence. Ecohealth 11:619–32 [Google Scholar]
  41. Keesing F, Belden LK, Daszak P, Dobson A, Harvell CD. 41.  et al. 2010. Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature 468:647–52 [Google Scholar]
  42. Pongsiri MJ, Roman J, Ezenwa VO, Goldberg TL, Koren HS. 42.  et al. 2009. Biodiversity loss affects global disease ecology. Bioscience 59:945–54 [Google Scholar]
  43. Arthur RF, Gurley ES, Salje H, Bloomfield LS, Jones JH. 43.  2017. Contact structure, mobility, environmental impact and behaviour: the importance of social forces to infectious disease dynamics and disease ecology. Philos. Trans. R. Soc. Lond. B Biol. Sci. 372:20160454 [Google Scholar]
  44. Hassell JM, Begon M, Ward MJ, Fevre EM. 44.  2017. Urbanization and disease emergence: dynamics at the wildlife-livestock-human interface. Trends Ecol. Evol. 32:55–67 [Google Scholar]
  45. Rogalski MA, Gowler CD, Shaw CL, Hufbauer RA, Duffy MA. 45.  2017. Human drivers of ecological and evolutionary dynamics in emerging and disappearing infectious disease systems. Philos. Trans. R. Soc. Lond. B Biol. Sci. 372:20160043 [Google Scholar]
  46. Wolfe ND, Daszak P, Kilpatrick AM, Burke DS. 46.  2005. Bushmeat hunting, deforestation, and prediction of zoonoses emergence. Emerg. Infect. Dis. 11:1822–27 [Google Scholar]
  47. Machovina B, Feeley KJ, Ripple WJ. 47.  2015. Biodiversity conservation: The key is reducing meat consumption. Sci. Total Environ. 536:419–31 [Google Scholar]
  48. Liu Q, He B, Huang SY, Wei F, Zhu XQ. 48.  2014. Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. Lancet Infect. Dis. 14:763–72 [Google Scholar]
  49. de Wit E, van Doremalen N, Falzarano D, Munster VJ. 49.  2016. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 14:523–34 [Google Scholar]
  50. Croser EL, Marsh GA. 50.  2013. The changing face of the henipaviruses. Vet. Microbiol. 167:151–58 [Google Scholar]
  51. Shepherd AJ, Swanepoel R, Leman PA, Shepherd SP. 51.  1987. Field and laboratory investigation of Crimean-Congo haemorrhagic fever virus (Nairovirus, family Bunyaviridae) infection in birds. Trans. R. Soc. Trop. Med. Hyg. 81:1004–7 [Google Scholar]
  52. Robertson K, Lumlertdacha B, Franka R, Petersen B, Bhengsri S. 52.  et al. 2011. Rabies-related knowledge and practices among persons at risk of bat exposures in Thailand. PLOS Negl. Trop. Dis. 5:e1054 [Google Scholar]
  53. Suwannarong K, Schuler S. 53.  2016. Bat consumption in Thailand. Infect. Ecol. Epidemiol. 6:29941 [Google Scholar]
  54. Karesh WB, Noble E. 54.  2009. The bushmeat trade: increased opportunities for transmission of zoonotic disease. Mt. Sinai J. Med. 76:429–34 [Google Scholar]
  55. Kamins AO, Restif O, Ntiamoa-Baidu Y, Suu-Ire R, Hayman DT. 55.  et al. 2011. Uncovering the fruit bat bushmeat commodity chain and the true extent of fruit bat hunting in Ghana, West Africa. Biol. Conserv. 144:3000–8 [Google Scholar]
  56. Brashares JS, Golden CD, Weinbaum KZ, Barrett CB, Okello GV. 56.  2011. Economic and geographic drivers of wildlife consumption in rural Africa. PNAS 108:13931–36 [Google Scholar]
  57. Ordaz-Nemeth I, Arandjelovic M, Boesch L, Gatiso T, Grimes T. 57.  et al. 2017. The socio-economic drivers of bushmeat consumption during the West African Ebola crisis. PLOS Negl. Trop. Dis. 11:e0005450 [Google Scholar]
  58. Judson SD, Fischer R, Judson A, Munster VJ. 58.  2016. Ecological contexts of index cases and spillover events of different ebolaviruses. PLOS Pathog 12:e1005780 [Google Scholar]
  59. Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V. 59.  et al. 2005. Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. PNAS 102:7994–99 [Google Scholar]
  60. Quiner CA, Moses C, Monroe BP, Nakazawa Y, Doty JB. 60.  et al. 2017. Presumptive risk factors for monkeypox in rural communities in the Democratic Republic of the Congo. PLOS ONE 12:e0168664 [Google Scholar]
  61. Gessain A, Rua R, Betsem E, Turpin J, Mahieux R. 61.  2013. HTLV-3/4 and simian foamy retroviruses in humans: discovery, epidemiology, cross-species transmission and molecular virology. Virology 435:187–99 [Google Scholar]
  62. Sabuni LP. 62.  2007. Dilemma with the local perception of causes of illnesses in central Africa: muted concept but prevalent in everyday life. Qual. Health Res. 17:1280–91 [Google Scholar]
  63. Hewlett BS, Amola RP. 63.  2003. Cultural contexts of Ebola in northern Uganda. Emerg. Infect. Dis. 9:1242–48 [Google Scholar]
  64. Jalloh MF, Bunnell R, Robinson S, Jalloh MB, Barry AM. 64.  et al. 2017. Assessments of Ebola knowledge, attitudes and practices in Forecariah, Guinea and Kambia, Sierra Leone, July-August 2015.. Philos. Trans. R. Soc. Lond. B Biol. Sci. 372:20160304 [Google Scholar]
  65. Miller M, Hagan E. 65.  2017. Integrated biological-behavioural surveillance in pandemic-threat warning systems. Bull. World Health Organ. 95:62–68 [Google Scholar]
  66. Richards P, Amara J, Ferme MC, Kamara P, Mokuwa E. 66.  et al. 2015. Social pathways for Ebola virus disease in rural Sierra Leone, and some implications for containment. PLOS Negl. Trop. Dis. 9:e0003567 [Google Scholar]
  67. Manguvo A, Mafuvadze B. 67.  2015. The impact of traditional and religious practices on the spread of Ebola in West Africa: time for a strategic shift. Pan Afr. Med. J. 22:Suppl. 19 [Google Scholar]
  68. Alexander KA, Sanderson CE, Marathe M, Lewis BL, Rivers CM. 68.  et al. 2015. What factors might have led to the emergence of Ebola in West Africa?. PLOS Negl. Trop. Dis. 9:e0003652 [Google Scholar]
  69. Kinsman J. 69.  2012. “A time of fear”: local, national, and international responses to a large Ebola outbreak in Uganda. Glob. Health 8:15 [Google Scholar]
  70. Nielsen CF, Kidd S, Sillah AR, Davis E, Mermin J, Kilmarx PH. 70.  2015. Improving burial practices and cemetery management during an Ebola virus disease epidemic—Sierra Leone, 2014.. Morb. Mortal. Wkly. Rep. 64:20–27 [Google Scholar]
  71. Richardson ET, Bailor Barrie M, Daniel Kelly J, Dibba Y, Koedoyoma S, Farmer PE. 71.  2016. Biosocial approaches to the 2013–2016 Ebola pandemic. Health Hum. Rights 18:115–28 [Google Scholar]
  72. Shultz JM, Cooper JL, Baingana F, Oquendo MA, Espinel Z. 72.  et al. 2016. The role of fear-related behaviors in the 2013–2016 West Africa Ebola virus disease outbreak. Curr. Psychiatry Rep. 18:104 [Google Scholar]
  73. Gulland A. 73.  2014. Agencies remain in Guinea despite killings of health workers. BMJ 349:g5807 [Google Scholar]
  74. Morens DM, Fauci AS. 74.  2013. Emerging infectious diseases: threats to human health and global stability. PLOS Pathog 9:e1003467 [Google Scholar]
  75. Karesh WB, Dobson A, Lloyd-Smith JO, Lubroth J, Dixon MA. 75.  et al. 2012. Ecology of zoonoses: natural and unnatural histories. Lancet 380:1936–45 [Google Scholar]
  76. Alemnji GA, Zeh C, Yao K, Fonjungo PN. 76.  2014. Strengthening national health laboratories in sub-Saharan Africa: a decade of remarkable progress. Trop. Med. Int. Health 19:450–58 [Google Scholar]
  77. Taboy CH, Chapman W, Albetkova A, Kennedy S, Rayfield MA. 77.  2010. Integrated disease investigations and surveillance planning: a systems approach to strengthening national surveillance and detection of events of public health importance in support of the International Health Regulations. BMC Public Health 10:Suppl. 1S6 [Google Scholar]
  78. Tran PD, Vu LN, Nguyen HT, Phan LT, Lowe W. 78.  et al. 2014. Strengthening global health security capacity—Vietnam demonstration project, 2013.. Morb. Mortal. Wkly. Rep. 63:77–80 [Google Scholar]
  79. Borchert JN, Tappero JW, Downing R, Shoemaker T, Behumbiize P. 79.  et al. 2014. Rapidly building global health security capacity—Uganda demonstration project, 2013.. Morb. Mortal. Wkly. Rep. 63:73–76 [Google Scholar]
  80. 80. World Health Organ. 2016. International Health Regulations 2005 Geneva: World Health Organ, 3rd ed.. [Google Scholar]
  81. 81. World Health Organ. 2017. Strengthening Health Security by Implementing the International Health Regulations (2005) Geneva: World Health Organ http://www.who.int/ihr/procedures/en/ [Google Scholar]
  82. 82. World Bank. 2012. People, Pathogens and Our Planet: The Economics of One Health Washington, DC: World Bank [Google Scholar]
  83. World Bank. 83.  2012. People, Pathogens and Our Planet 2 The Economics of One Health Washington, DC: World Bank [Google Scholar]
  84. Amman BR, Carroll SA, Reed ZD, Sealy TK, Balinandi S. 84.  et al. 2012. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLOS Pathog 8:e1002877 [Google Scholar]
  85. Luis AD, Douglass RJ, Mills JN, Bjornstad ON. 85.  2010. The effect of seasonality, density and climate on the population dynamics of Montana deer mice, important reservoir hosts for Sin Nombre hantavirus. J. Anim. Ecol. 79:462–70 [Google Scholar]
  86. Oldstone MB. 86.  2006. Viral persistence: parameters, mechanisms and future predictions. Virology 344:111–18 [Google Scholar]
  87. Sridhar S, To KK, Chan JF, Lau SK, Woo PC, Yuen KY. 87.  2015. A systematic approach to novel virus discovery in emerging infectious disease outbreaks. J. Mol. Diagn. 17:230–41 [Google Scholar]
  88. Erickson BR, Sealy TK, Flietstra T, Morgan L, Kargbo B. 88.  et al. 2016. Ebola virus disease diagnostics, Sierra Leone: analysis of real-time reverse transcription-polymerase chain reaction values for clinical blood and oral swab specimens. J. Infect. Dis. 214:S258–S62 [Google Scholar]
  89. Bird BH, Ksiazek TG, Nichol ST, MacLachlan NJ. 89.  2009. Rift Valley fever virus. J. Am. Vet. Med. Assoc. 234:883–93 [Google Scholar]
  90. Zumla A, Al-Tawfiq JA, Enne VI, Kidd M, Drosten C. 90.  et al. 2014. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects. Lancet Infect. Dis. 14:1123–35 [Google Scholar]
  91. Moustafa A, Xie C, Kirkness E, Biggs W, Wong E. 91.  et al. 2017. The blood DNA virome in 8,000 humans. PLOS Pathog 13:e1006292 [Google Scholar]
  92. Chiu CY. 92.  2013. Viral pathogen discovery. Curr. Opin. Microbiol. 16:468–78 [Google Scholar]
  93. Radford A, Bushell C. 93.  2012. How new sequencing technologies will help shape the future. Vet. Rec. 170:471 [Google Scholar]
  94. Radford AD, Chapman D, Dixon L, Chantrey J, Darby AC, Hall N. 94.  2012. Application of next-generation sequencing technologies in virology. J. Gen. Virol. 93:1853–68 [Google Scholar]
  95. Anthony SJ, Islam A, Johnson C, Navarrete-Macias I, Liang E. 95.  et al. 2015. Non-random patterns in viral diversity. Nat. Commun. 6:8147 [Google Scholar]
  96. Linhart C, Shamir R. 96.  2005. The degenerate primer design problem: theory and applications. J. Comput. Biol. 12:4431–56 [Google Scholar]
  97. Souvenir R, Buhler J, Stormo G, Zhang W. 97.  2007. An iterative method for selecting degenerate multiplex PCR primers. Methods Mol. Biol. 402:245–68 [Google Scholar]
  98. Broadhurst MJ, Brooks TJ, Pollock NR. 98.  2016. Diagnosis of Ebola virus disease: past, present, and future. Clin. Microbiol. Rev. 29:773–93 [Google Scholar]
  99. Xu GJ, Kula T, Xu Q, Li MZ, Vernon SD. 99.  et al. 2015. Viral immunology: comprehensive serological profiling of human populations using a synthetic human virome. Science 348:aaa0698 [Google Scholar]
  100. Courbet A, Renard E, Molina F. 100.  2016. Bringing next-generation diagnostics to the clinic through synthetic biology. EMBO Mol. Med. 8:987–91 [Google Scholar]
  101. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 101.  1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–62 [Google Scholar]
  102. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M. 102.  et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791–96 [Google Scholar]
  103. Burkle FM Jr.. 103.  2015. Global health security demands a strong international health regulations treaty and leadership from a highly resourced World Health Organization. Disaster Med. Public Health Prep. 9:568–80 [Google Scholar]
  104. Mazet JA, Clifford DL, Coppolillo PB, Deolalikar AB, Erickson JD, Kazwala RR. 104.  2009. A “one health” approach to address emerging zoonoses: the HALI project in Tanzania. PLOS Med 6:e1000190 [Google Scholar]
  105. Albarino CG, Foltzer M, Towner JS, Rowe LA, Campbell S. 105.  et al. 2014. Novel paramyxovirus associated with severe acute febrile disease, South Sudan and Uganda, 2012.. Emerg. Infect. Dis. 20:211–16 [Google Scholar]
  106. Paton NI, Leo YS, Zaki SR, Auchus AP, Lee KE. 106.  et al. 1999. Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet 354:1253–56 [Google Scholar]
  107. Phan JC, Pettitt J, George JS, Fakoli LS 3rd, Taweh FM. 107.  et al. 2016. Lateral flow immunoassays for Ebola virus disease detection in Liberia. J. Infect. Dis. 214:S222–S28 [Google Scholar]
  108. Cazacu AC, Greer J, Taherivand M, Demmler GJ. 108.  2003. Comparison of lateral-flow immunoassay and enzyme immunoassay with viral culture for rapid detection of influenza virus in nasal wash specimens from children. J. Clin. Microbiol. 41:2132–34 [Google Scholar]
  109. Towner JS, Sealy TK, Khristova ML, Albarino CG, Conlan S. 109.  et al. 2008. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLOS Pathog 4:e1000212 [Google Scholar]
  110. Bowen MD, Trappier SG, Sanchez AJ, Meyer RF, Goldsmith CS. 110.  et al. 2001. A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. Virology 291:185–90 [Google Scholar]
  111. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG. 111.  et al. 1993. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262:914–17 [Google Scholar]
  112. Anthony SJ, Gilardi K, Menachery VD, Goldstein T, Ssebide B. 112.  et al. 2017. Further evidence for bats as the evolutionary source of Middle East respiratory syndrome coronavirus. mBio 8:e00373–17 [Google Scholar]
  113. Grard G, Fair JN, Lee D, Slikas E, Steffen I. 113.  et al. 2012. A novel rhabdovirus associated with acute hemorrhagic fever in central Africa. PLOS Pathog 8:e1002924 [Google Scholar]
  114. Xu B, Liu L, Huang X, Ma H, Zhang Y. 114.  et al. 2011. Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLOS Pathog 7:e1002369 [Google Scholar]
  115. Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD. 115.  et al. 2011. Fever with thrombocytopenia associated with a novel bunyavirus in China. N. Engl. J. Med. 364:1523–32 [Google Scholar]
/content/journals/10.1146/annurev-animal-030117-014628
Loading
/content/journals/10.1146/annurev-animal-030117-014628
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error